US FDA halts approval for plasma therapy to treat Covid: Report

Blood plasma therapy that is being touted as the final resort to treat Covid-19 has not convinced the US Food and Drug Administration (FDA) as it has put the emergency use authorisation for blood plasma to treat the deadly respiratory disease on hold, the media reported.

Read the Rest at INDIA TV

Leave a Reply

Your email address will not be published. Required fields are marked *